Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt ...

In July, MSD and Moderna decided to take the combination of the vaccine and Keytruda into a phase 3 trial called INTerpath-001 (formerly V940-001) for skin cancer melanoma, once again as an ...

Get the latest science news and technology news, read tech reviews and more at ABC News.

As AI-generated voices become more sophisticated and cost-effective, voice actor industry associations across Europe are calling on the EU to tighten regulations to protect quality, jobs and ...